Nexus Surgical And Medicare Ltd
Nexus Surgical And Medicare Ltd (NEXUSSURGL) last reported results for the quarter ended Jun 2026, with sales of ₹2.55 crore and net profit of ₹0.2 crore. The stock last traded at ₹32.6, a market capitalisation of ₹17.8 crore, on a P/E of 22.8. Over the past 52 weeks the stock has ranged between ₹13.3 and ₹35.8. Figures are as of 6 Oct 2026 and are not real time.
Nexus Surgical And Medicare Ltd share price and key metrics
- Current price
- ₹32.6
- Market cap
- ₹17.8 cr
- Stock P/E
- 22.8
- Book value
- ₹3.29
- ROE
- 51.8%
- ROCE
- 69.9%
- Dividend yield
- 0.00%
- 52w high / low
- 35.8/13.3
Metrics as of 6 Oct 2026. Not real time.
Track Nexus Surgical And Medicare Ltd
Cruxal reads every Nexus Surgical And Medicare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Nexus Surgical And Medicare Ltd growth and returns
- 10 Years
- 37%
- 5 Years
- 16%
- 3 Years
- 72%
- TTM
- 53%
- 10 Years
- 31%
- 5 Years
- 38%
- 3 Years
- 63%
- TTM
- 39%
- 10 Years
- -4%
- 5 Years
- 65%
- 3 Years
- 40%
- 1 Year
- 96%
- 10 Years
- %
- 5 Years
- 64%
- 3 Years
- 54%
- Last Year
- 52%
Nexus Surgical And Medicare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹2.55 cr, up 47.4% from ₹1.73 cr a year earlier. Net profit was ₹0.2 cr, up 33.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.99 | 1.48 | 1.48 | 1.73 | 1.17 | 2.93 | 2.05 | 2.55 |
| Expenses | 0.71 | 1.33 | 1.37 | 1.53 | 0.94 | 2.71 | 1.75 | 2.31 |
| Operating profit | 0.28 | 0.15 | 0.11 | 0.2 | 0.23 | 0.22 | 0.3 | 0.24 |
| OPM % | 28.28% | 10.14% | 7.43% | 11.56% | 19.66% | 7.51% | 14.63% | 9.41% |
| Other income | 0 | 0 | 0.01 | 0 | 0 | 0.01 | 0.02 | 0.03 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.28 | 0.15 | 0.12 | 0.2 | 0.23 | 0.23 | 0.32 | 0.27 |
| Tax % | 25.00% | 26.67% | 25.00% | 25.00% | 26.09% | 26.09% | 25.00% | 25.93% |
| Net profit | 0.21 | 0.11 | 0.09 | 0.15 | 0.17 | 0.17 | 0.24 | 0.2 |
| EPS (₹) | 0.38 | 0.20 | 0.16 | 0.27 | 0.31 | 0.31 | 0.44 | 0.37 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Nexus Surgical And Medicare Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.3 | 0.98 | 2.14 | 1.73 | 3.74 | 2.4 | 1.55 | 3.47 | 5.72 | 7.87 | 8.7 |
| Operating profit | -0.18 | -0.38 | -0.18 | 0.07 | 0.16 | 0.37 | 0.22 | 0.27 | 0.67 | 0.97 | 0.99 |
| OPM % | -60.00% | -38.78% | -8.41% | 4.05% | 4.28% | 15.42% | 14.19% | 7.78% | 11.71% | 12.33% | 11.38% |
| Net profit | -0.19 | -0.33 | -0.11 | -5.3 | 0.15 | 0.29 | 0.17 | 0.21 | 0.5 | 0.74 | 0.78 |
| EPS (₹) | -0.35 | -0.60 | -0.20 | -9.69 | 0.27 | 0.53 | 0.31 | 0.38 | 0.91 | 1.35 | 1.43 |
TTM is the trailing twelve months to the most recent quarter.
Nexus Surgical And Medicare Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 |
| Reserves | 0.00 | -0.33 | -0.44 | -5.73 | -5.58 | -5.29 | -5.12 | -4.91 | -4.41 | -3.67 |
| Borrowings | 0.29 | 0.25 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other liabilities | 0.18 | 0.20 | 0.20 | 0.47 | 1.04 | 1.82 | 0.56 | 1.25 | 1.21 | 1.85 |
| Total liabilities | 5.94 | 5.59 | 5.49 | 0.21 | 0.93 | 2.00 | 0.91 | 1.81 | 2.27 | 3.65 |
| Fixed assets | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| CWIP | 5.35 | 5.35 | 5.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 0.56 | 0.22 | 0.12 | 0.19 | 0.91 | 1.99 | 0.89 | 1.79 | 2.25 | 3.63 |
| Total assets | 5.94 | 5.59 | 5.49 | 0.21 | 0.93 | 2.00 | 0.91 | 1.81 | 2.27 | 3.65 |
As reported by the company. Total assets equal total liabilities by construction.
Nexus Surgical And Medicare Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -0.17 | -0.07 | 0.02 | 0.24 | 0.20 | -0.11 | 0.55 | -0.41 | 0.10 | 0.17 |
| Cash from investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Cash from financing | 0.20 | -0.04 | 0.01 | -0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net cash flow | 0.03 | -0.11 | 0.03 | -0.02 | 0.20 | -0.11 | 0.54 | -0.42 | 0.10 | 0.17 |
| Free cash flow | -0.17 | -0.07 | 0.02 | 0.24 | 0.20 | -0.11 | 0.54 | -0.41 | 0.09 | 0.17 |
| CFO / operating profit | 94% | 18% | -11% | 343% | 125% | -30% | 250% | -152% | 15% | 18% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Nexus Surgical And Medicare Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -3.13% | -5.74% | -1.87% | 2.78% | — | 1,114.29% | 86.79% | 65.93% | 83.95% | 69.93% |
| Debtor days | 292.00 | 37.24 | 6.82 | 0.00 | 11.71 | 0.00 | 9.42 | 78.89 | 85.51 | 61.22 |
| Inventory days | 138.45 | 15.21 | 0.00 | 0.00 | 0.00 | — | 56.78 | 243.33 | 83.93 | 55.35 |
| Days payable | 226.55 | 72.24 | — | — | — | — | 454.22 | 754.33 | 230.32 | 239.34 |
| Cash conversion cycle | 203.90 | -19.79 | 6.82 | 0.00 | 11.71 | 0.00 | -388.03 | -432.11 | -60.88 | -122.78 |
| Working capital days | -73.00 | -100.56 | -66.52 | -73.84 | -43.92 | -19.77 | -77.71 | 29.45 | 44.67 | 58.90 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Nexus Surgical And Medicare Ltd shareholding pattern
Promoters held 18.73% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% |
| Public | 81.27% | 81.27% | 81.26% | 81.26% | 81.27% | 81.28% | 81.28% | 81.27% |
| No. of shareholders | 5,102 | 5,866 | 6,024 | 6,137 | 6,048 | 5,997 | 5,858 | 5,743 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Nexus Surgical And Medicare Ltd corporate filings
- Submission of Intimation of Closure of Trading Window for the quarter and half year ended 30th September, 2026Insider Trading / SASTlow impact
- Nexus Surgical and Medicare Limited announces re-appointment of Independent DirectorCompany Updatelow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has formally announced the re-appointment of Ms. Neha…
Read the full analysis - Nexus Surgical and Medicare Limited Announces Appointment of Independent DirectorCompany Updatelow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has formally announced the appointment of Mr. Ashish…
Read the full analysis - Nexus Surgical and Medicare Limited announces re-designation of Mr. Ram Swaroop Joshi to Promoter Non-Executive DirectorCompany Updatelow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has formally announced that shareholders at the 35th…
Read the full analysis - Nexus Surgical and Medicare Limited Appoints Mr. Anish More as Managing DirectorCompany Updatemedium impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has formally appointed Mr. Anish More as Managing…
Read the full analysis - Nexus Surgical and Medicare Limited Announces Voting Results of 35th AGM; Key Management Changes ApprovedAGM/EGMmedium impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has successfully concluded its 35th Annual General…
Read the full analysis - Nexus Surgical and Medicare Limited Concludes 35th Annual General Meeting with Board ReconstitutionsAGM/EGMlow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has successfully concluded its 35th Annual General…
Read the full analysis - Nexus Surgical and Medicare Ltd clarifies recent stock price movementCompany Updatelow impact
Cruxal's analysis: Nexus Surgical and Medicare Ltd has responded to a clarification request from the…
Read the full analysis - Nexus Surgical And Medicare Ltd submits Annual Report for F.Y. 2025-26Otherslow impact
Cruxal's analysis: Nexus Surgical And Medicare Ltd has filed its Annual Report for the financial year…
Read the full analysis - Nexus Surgical and Medicare Limited Announces Management Reshuffle and 35th AGM NoticeAGM/EGMmedium impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has scheduled its 35th Annual General Meeting for…
Read the full analysis - Nexus Surgical and Medicare Limited schedules 35th Annual General Meeting for September 25, 2026AGM/EGMlow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has formally announced the scheduling of its 35th…
Read the full analysis - Nexus Surgical and Medicare Ltd reconstitutes key board committeesCompany Updatelow impact
Cruxal's analysis: The Board of Directors of Nexus Surgical and Medicare Ltd approved the reconstitution of…
Read the full analysis - Nexus Surgical and Medicare Limited Announces Re-appointment of Independent Director for Second Five-Year TermCompany Updatelow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has formally announced the re-appointment of Ms. Neha…
Read the full analysis - Nexus Surgical and Medicare Limited appoints Ashish Durgaprasad Mishra as Independent Non-Executive DirectorCompany Updatelow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has announced the appointment of Mr. Ashish…
Read the full analysis - Nexus Surgical and Medicare Limited Appoints Tech-Focused Managing Director to Drive AI-Led StrategyCompany Updatemedium impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has appointed Mr. Anish More as an Additional…
Read the full analysis - Nexus Surgical and Medicare Limited: Managing Director Ram Swaroop Joshi resigns, transitions to Promoter Non-Executive DirectorCompany Updatelow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has announced that Mr. Ram Swaroop Joshi has resigned…
Read the full analysis - Nexus Surgical and Medicare Limited Announces Leadership Transition and 35th Annual General Meeting ScheduleBoard Meetingmedium impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has announced a significant leadership transition…
Read the full analysis - Nexus Surgical and Medicare Limited schedules Board Meeting for September 2, 2026, to approve FY26 Audited Financials and AGM logisticsBoard Meetinglow impact
Cruxal's analysis: Nexus Surgical and Medicare Limited has announced a board meeting scheduled for September…
Read the full analysis - Nexus Surgical and Medicare Limited reports Q1 FY27 revenue of 2.55 crore with net profit of 20.42 lakhResulthigh impact
Cruxal's analysis: Nexus Surgical and Medicare Limited reported a strong performance for the quarter ended…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.